You are here: Industry Insights > biotech

News List

Another BlockBuster in HKEX18A Biotech Companies: IPO of DualityBio in Hong Kong, Introducing New Capital Engine in the ADC Field? Kevin
April 15, 2025
On April 15, DualityBio, a rising star in the ADC field, was officially listed on the HKEX, marking one of the most high-profile IPOs in recent years in Chapter 18A Biotech Companies.
Regenerative Medicine and Drug Development: The Intersection of Stem Cells and Biotech Nurah Ekhlaque
January 17, 2025
Explore how regenerative medicine and biotech are transforming drug development with stem cell therapies, personalised treatments, and innovative solutions.
Global approvals of new innovative drugs by Chinese biotech companies Deborah Seah
February 20, 2023
Novel Drug approvals in 2022；Approval of Chinese drug potentials in the global market.
Going Global Successfully! BCMA CAR-T of Legend Biotech is Approved by FDA for Marketing! PharmaSources/Small pill
March 16, 2022
On February 28 local time, LEGN.US officially announced in Somerset, New Jersey, U.S., that its self-developed BCMA-targeted CAR-T therapy, ciltacabtagene autoleucel (trade name: CARVYKTI?), abbreviated as Cilta-cel, was approved for marketing by the FDA.
Established For Non-Sterile API and Pharmaceutical Intermediates, Ningxia Taiyicin Biotech Co., LTD. PharmaSources.com
December 30, 2021
Ningxia Taiyicin founded in 2010, covering about 221.73 hectares of construction area with registered capital RMB 625 million, is mainly established for Non-sterile API and pharmaceutical intermediates.
Rec-Biotechnology Went to Hong Kong, S.A.R., China IPO, Aiming at the HPV Vaccine Market Worth Tens of Billions and Creating an Innovation Engine of Comprehensive Vaccine PharmaSources/Yefenghong
August 02, 2021
On July 16, Rec-Biotechnology submitted its prospectus to HKEX and was accepted. Rec-Biotechnology is an innovative vaccine company, and its core product, Human Papillomavirus 9-valent Vaccine, Recombinant, is in Phase III clinical trial stage.
Discovering Biotechnology: Trends in China’s Pharmaceutical Industry in 2020 Deborah Seah
December 24, 2020
As the world’s manufacturing hub, China has boost its pharmaceutical market over the past decade to become one of the fastest growing and most competitive markets.
Discovering Biotechnology: Developments in COVID-19 Diagnostic tests Deborah Seah
November 09, 2020
Diagnostic tests by definition are any method used to obtain information of a patient’s clinical condition for healthcare professionals to make an informed clinical decision.
Discovering Biotechnology: Top 9 Chinese Pharmaceutical Companies in 2020 Deborah Seah
November 04, 2020
China 's pharmaceutical industry garnered a total revenue of about 2.6 trillion yuan in 2019 amounting to an eight percent year-on-year growth.
Discovering Biotechnology: 5 Innovations Shaping the Future of Medicine Deborah Seah
June 23, 2020
“Innovation” the act of alteration and transformation is crucial for progress and meeting the changing needs of a dynamic society.